O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.15B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$186M
2
+$115M
3
+$60.8M
4
ABBV icon
AbbVie
ABBV
+$53.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.4M

Top Sells

1
+$83.2M
2
+$60M
3
+$58.4M
4
UNH icon
UnitedHealth
UNH
+$56.5M
5
CELG
Celgene Corp
CELG
+$53.8M

Sector Composition

1 Healthcare 86.06%
2 Technology 0.09%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$4.95M 0.06%
1,363,500
-80,000
102
$4.88M 0.06%
795,400
+95,400
103
$4.72M 0.06%
63,000
-1,110,100
104
$4.28M 0.05%
1,895,000
105
$3.99M 0.05%
39,620
+12,500
106
$3.8M 0.05%
+300,000
107
$3.67M 0.05%
+271,700
108
$3.13M 0.04%
116,594
109
$2.96M 0.04%
+196,000
110
$2.53M 0.03%
1,892
111
$1.67M 0.02%
300,000
-150,000
112
$1.09M 0.01%
13,333
-4,915
113
$724K 0.01%
20,000
-10,000
114
– –
-135,000
115
– –
0
116
– –
0
117
– –
-449,204
118
– –
-429,000
119
– –
0
120
– –
0
121
– –
0
122
– –
-200,000
123
– –
0
124
– –
-55,000
125
– –
-34,500
2 3 4
5
6